These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4600155)

  • 1. [Non-hormonal treatment of hot flashes and other menopausal disorders].
    Ruf H; Lanza M
    Therapeutique; 1973 Dec; 49(10):703-5. PubMed ID: 4600155
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of inadequate lactation with oral sulpiride and buccal oxytocin.
    Ylikorkala O; Kauppila A; Kivinen S; Viinikka L
    Obstet Gynecol; 1984 Jan; 63(1):57-60. PubMed ID: 6361642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A multicenter comparison of veralipride versus placebo in the vasomotor flushes of menopause. An evaluation of the prolonged effect].
    Boulot P; Viala JL
    Rev Fr Gynecol Obstet; 1988 Dec; 83(12):823-7. PubMed ID: 3064254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of menopausal vasomotor symptoms.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1137-9. PubMed ID: 15863558
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulpiride and lactation.
    Fondu F
    Brux Med; 1975 Mar; 55(3):147-58. PubMed ID: 1227717
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment.
    Rapkin AJ
    Am J Obstet Gynecol; 2007 Feb; 196(2):97-106. PubMed ID: 17306645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-hormonal treatments for menopausal symptoms.
    Hickey M; Saunders CM; Stuckey BG
    Maturitas; 2007 May; 57(1):85-9. PubMed ID: 17367965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.
    Alexander JL; Burger H; Dennerstein L; Woods NF; Davis SR; Kotz K; Van Winkle J; Richardson G; Ratka A; Kessel B
    Expert Rev Neurother; 2007 Nov; 7(11 Suppl):S115-37. PubMed ID: 18039061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of a new non-steroid drug in the menopausal syndrome and in inhibition of lactation].
    Pastore R; Pagliarello F
    Riv Ital Ginecol; 1976; 57(1):37-42. PubMed ID: 800676
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sulpiride in the treatment of migraine, tension headache and associated psychosomatic disorders].
    Hakkarainen H; Viukari M
    Duodecim; 1973 Aug; 89(22):1504-9. PubMed ID: 4587835
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of veralipride for the treatment of vasomotor symptoms of menopause.
    Valencia MH; Arias Mde J; González CC; Marín IH; González JH; Campos ER; Rodríguez MA; Álvarez IM; Vargas MA; Flores JB; Haro SS; Bonilla MC; Escudero RB; Campero RA
    Menopause; 2014 May; 21(5):484-92. PubMed ID: 24065139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-menopausal hot flushes and parkinsonism].
    Marinas A; Gutiérrez-Gutiérrez G; Martí-Massó JF
    Rev Neurol; 2004 Nov 1-15; 39(9):896-7. PubMed ID: 15543509
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy and clinical and biological tolerance of long-term veralipride administration. Apropos of 74 case reports].
    Dargent D; Dumont M; Malinas Y
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):171-3. PubMed ID: 3992114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of menopausal vasomotor symptoms.
    Med Lett Drugs Ther; 2004 Dec 6-20; 47(1197-1198):98-9. PubMed ID: 15583526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrasorb.
    Chiechi LM
    IDrugs; 2004 Sep; 7(9):860-4. PubMed ID: 15470604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Further therapeutic effects of Frideron].
    Cazzola D; Confalonieri A; Lucchese V
    Minerva Ginecol; 1973 Feb; 25(2):112-6. PubMed ID: 4572422
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.
    Goodwin JW; Green SJ; Moinpour CM; Bearden JD; Giguere JK; Jiang CS; Lippman SM; Martino S; Albain KS
    J Clin Oncol; 2008 Apr; 26(10):1650-6. PubMed ID: 18375894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies.
    Keenan NL; Mark S; Fugh-Berman A; Browne D; Kaczmarczyk J; Hunter C
    Menopause; 2003; 10(6):507-15. PubMed ID: 14627858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New data on the physiology and treatment of vasomotor menopausal flushing].
    Buvat J; Buvat-Herbaut M
    LARC Med; 1983 Apr; 3(4):236, 241, 243-5. PubMed ID: 6137742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.